Repro Med Systems Inc (REPR)

[blue_skies]

MWM - A lot of people got frustrated waiting - nothing happened for years.

Look at this as a new company - one you had just heard about. Thats how I see it, a new company with new management and a bright future.

The company culture has changed from passively taking orders to actively exploring opportunities. The movement of drugs to home infusions is a win/win/win. The patients win, the pharma wins and RMS wins. Pharma is re configuring drugs for home infusion. As more drugs and drug makers do this then the potential for RMS medical growth is exponential. This is being done by a company with a strong balance sheet (no long term debt).

What is not understood is that currently a large percent of RMS medical revenue is associated with a single subq drug, CSL Behring's Hizentra. The company is actively focusing on fostering additional partnership.

The RMS business model is "give" the user the pump and make money on the needles and tubing. Needles and tubing become a recurring revenue stream. SubQ infusion take less time to administer then IV infusions because subc can be pumped to multiple sites simultaneously. The patient saves time and RMS sells more needles and tubing. Everyone wins!